株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血管アクセスデバイスの世界市場 - 2022年までの予測:タイプ 、用途 (投薬、液体・栄養投与)、エンドユーザー別

Vascular Access Device Market by Type (Peripheral (Midline, Short), Central (PICC, Tunneled, Non-Tunneled, Implanted Ports), Accessories), Application (Drug Administration, Fluid & Nutrition Administration) & End Users - Global Forecasts to 2022

発行 MarketsandMarkets 商品コード 534646
出版日 ページ情報 英文 141 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.97円で換算しております。
Back to Top
血管アクセスデバイスの世界市場 - 2022年までの予測:タイプ 、用途 (投薬、液体・栄養投与)、エンドユーザー別 Vascular Access Device Market by Type (Peripheral (Midline, Short), Central (PICC, Tunneled, Non-Tunneled, Implanted Ports), Accessories), Application (Drug Administration, Fluid & Nutrition Administration) & End Users - Global Forecasts to 2022
出版日: 2017年07月21日 ページ情報: 英文 141 Pages
概要

血管アクセスデバイス市場は2017年の38億7,000万米ドルから、CAGR7.1%で拡大し、2022年までに54億5,000万米ドルになると予測されています。生活習慣病の罹患率上昇、化学療法件数の増加、小児患者における血管アクセスデバイスの使用増加などが市場の成長を牽引しています。

当レポートでは、世界の血管アクセスデバイス市場について調査し、市場の概要とタイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

  • 当調査の目的
  • 市場の定義
  • 市場の範囲
  • 考慮される通貨
  • 限界
  • ステークホルダー

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 市場概要

  • イントロダクション
  • 市場の発展
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
    • 課題

第6章 タイプ別市場

  • イントロダクション
  • 中心血管アクセスデバイス
  • 末梢血管アクセスデバイス
  • アクセサリ

第7章 用途別市場

  • イントロダクション
  • 投薬
  • 液体・栄養投与
  • 輸血
  • 診断・検査

第8章 エンドユーザー別市場

  • イントロダクション
  • 病院
  • 診療所、外来ケアセンター
  • その他

第9章 地域別市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第10章 競合環境

  • 概要
  • 市場シェア分析
  • 市場ランキング
  • 競合リーダーシップマッピング
  • 競合ベンチマーキング

第11章 企業プロファイル

  • BECTON, DICKINSON AND COMPANY
  • C.R.BARD, INC.
  • TELEFLEX INCORPORATED
  • SMITHS MEDICAL, INC.
  • B BRAUN MELSUNGEN AG
  • ANGIODYNAMICS (NAVILYST MEDICAL, INC)
  • TERUMO CORPORATION
  • NIPRO MEDICAL CORPORATION
  • EDWARDS LIFESCIENCES CORPORATION
  • AMECO MEDICAL
  • ROMSONS SCIENTIFIC & SURGICAL PVT. LTD.
  • PRODIMED

第12章 付録

目次
Product Code: MD 5434

"Vascular access devices market is projected to grow at a CAGR of 7.1%"

The global vascular access device market is estimated to grow at a CAGR of 7.1% to reach USD 5.45 billion by 2022 from USD 3.87 billion in 2017. The key factors driving the growth of this market include the growing prevalence of lifestyle diseases, an increase in the number of chemotherapy procedures and the increasing use of vascular access devices in pediatric patients. However, high costs involved in the placement and maintenance of vascular access devices and product recalls and failures may hinder the growth of the market to a certain extent during the forecast period.

"The central vascular access device segment to dominate the global vascular access devices market during the forecast period"

By type, the vascular access devices market is segmented into central vascular access devices, peripheral vascular access devices, and accessories. The central vascular access devices segment is not only expected to account for the largest share of the vascular access devices market in 2017, but also grow at the highest CAGR during the forecast period. The growth of this segment is attributed to the wide usage of central vascular access devices in chemotherapy and for the treatment of cardiovascular disorders and chronic kidney disorders.

"The drug administration segment is projected to grow at the highest CAGR during the forecast period"

On the basis of application, the vascular access devices market is segmented into drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing. The drug administration segment is expected to grow at the highest CAGR in 2017. This positive growth rate can primarily be attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases.

"Asia-Pacific to witness the highest growth during the forecast period (2017-2022)"

North America held the largest share of the global vascular access devices market in 2016, while Asia-Pacific is expected to witness the highest growth during 2017 to 2022. Rapid growth in aging population and CKD, CKS, & diabetes prevalence, along with healthcare reforms and investments in Asia-Pacific countries, are key factors driving the market for this geographic segment.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-55%, Tier 2-25% and Tier 3-20%
  • By Designation - C-level-43%, Director Level-32%, Others-25%
  • By Region - North America-38%, Europe-23%, Asia-Pacific-29%, RoW-10%

Some of the major players include Becton Dickinson and Company (U.S.), Smiths Medical, Inc. (U.K.), and C. R. Bard, Inc. (U.S.). Other players include Teleflex Incorporated (U.S.) B. Braun Melsungen Ag (Germany), AngioDynamics (U.S.), Terumo Corporation (Japan), Nipro Medical Corporation, Edwards Lifesciences Corporation (U.S.), Ameco Medical (Egypt), Romsons Scientific & Surgical Pvt. Ltd (India), and Prodimed (France).

Research Coverage:

The report analyzes the vascular access device market and aims at estimating the market size and future growth potential of this market based on various segments such as type, application, end user and region. The report also includes an in-depth regulatory analysis for various regions across the globe and the competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global vascular access devices market. The report analyzes the vascular access devices market by type, application, end user, and region.
  • Service Enhancement/Innovation: Detailed insights on upcoming trends and new service launches in the global vascular access devices market.
  • Market Development: Comprehensive information about the lucrative emerging markets by type, application, end user, and region.
  • Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the vascular access devices market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products and services of leading players in the global vascular access devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key insights from primary sources
    • 2.2.3. KEY INDUSTRY INSIGHTS
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET FORECAST METHODOLOGY
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS OF THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. VASCULAR ACCESS DEVICES: MARKET OVERVIEW (2017-2022)
  • 4.2. VASCULAR ACCESS DEVICES MARKET, BY TYPE (2017)
  • 4.3. VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2017 VS. 2022
  • 4.4. VASCULAR ACCESS DEVICES MARKET, BY END USER, 2017 VS. 2022
  • 4.5. GEOGRAPHIC SNAPSHOT OF THE VASCULAR ACCESS DEVICES MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growing prevalence of lifestyle diseases
      • 5.2.1.2. Increasing number of chemotherapy procedures
      • 5.2.1.3. Increasing use of vascular access devices in pediatric patients
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High costs involved in the placement and maintenance of vascular access devices
      • 5.2.2.2. Product recalls and failures
    • 5.2.3. OPPORTUNITY
      • 5.2.3.1. Technological advancements
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Shortage of skilled professionals
      • 5.2.4.2. Risks associated with vascular access devices

6. GLOBAL VASCULAR ACCESS DEVICES MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. CENTRAL VASCULAR ACCESS DEVICES
    • 6.2.1. PERIPHERALLY INSERTED CENTRAL CATHETERS
    • 6.2.2. TUNNELED CATHETERS
    • 6.2.3. NON-TUNNELED CATHETERS
    • 6.2.4. IMPLANTED PORTS
  • 6.3. PERIPHERAL VASCULAR ACCESS DEVICES
    • 6.3.1. PERIPHERAL SHORT DEVICES
    • 6.3.2. PERIPHERAL MIDLINE DEVICES
    • 6.3.3. BUTTERFLY/WINGED STEEL NEEDLES
  • 6.4. ACCESSORIES

7. GLOBAL VASCULAR ACCESS DEVICES MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. DRUG ADMINISTRATION
  • 7.3. FLUID AND NUTRITION ADMINISTRATION
  • 7.4. BLOOD TRANSFUSION
  • 7.5. DIAGNOSTICS AND TESTING

8. GLOBAL VASCULAR ACCESS DEVICES MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS
  • 8.3. CLINICS AND AMBULATORY CARE CENTERS
  • 8.4. OTHER END USERS

9. VASCULAR ACCESS DEVICES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
      • 9.2.1.1. Rising prevalence of CVD
      • 9.2.1.2. Increasing number of cancer cases
      • 9.2.1.3. Increase in research and clinical trials for vascular access devices
      • 9.2.1.4. Conferences, meetings, symposia, and workshops
    • 9.2.2. CANADA
      • 9.2.2.1. Increasing number of cardiac arrest cases
      • 9.2.2.2. Increase in cancer incidence
      • 9.2.2.3. Increasing number of minimally invasive procedures
  • 9.3. EUROPE
    • 9.3.1. INCREASING FOCUS OF MARKET PLAYERS ON EUROPE
    • 9.3.2. NEW RULES AND REGULATIONS FOR MEDICAL DEVICES
    • 9.3.3. RISING GERIATRIC POPULATION
    • 9.3.4. E-3
      • 9.3.4.1. Rising prevalence of CVD in U.K. and Germany
      • 9.3.4.2. Growing prevalence of cancer in EU-3
      • 9.3.4.3. Increasing prevalence of lifestyle diseases in the U.K.
      • 9.3.4.4. Favorable government support, growth in aging population in France
      • 9.3.4.5. Prevalence of ESRD and need for dialysis treatment
    • 9.3.5. ROE
      • 9.3.5.1. Improving healthcare structure in Russia
      • 9.3.5.2. Turkey: Growth in the healthcare sector, rising medical tourism
  • 9.4. ASIA-PACIFIC
    • 9.4.1. INCREASING CHRONIC KIDNEY DISEASE PREVALENCE IN JAPAN
    • 9.4.2. JAPAN & CHINA: RAPID GROWTH IN GERIATRIC POPULATION
    • 9.4.3. HEALTHCARE REFORMS, GOVERNMENT INITIATIVES, AND INVESTMENTS IN CHINA AND JAPAN
  • 9.5. REST OF THE WORLD
    • 9.5.1. PREVALENCE OF CKD AND GOVERNMENT INITIATIVES IN THE ROW
    • 9.5.2. MIDDLE EAST: INCREASING GERIATRIC POPULATION, RISE IN AGE-RELATED DISORDERS
    • 9.5.3. GROWING MEDICAL TOURISM IN THE ROW
    • 9.5.4. HIGH PREVALENCE OF OBESITY IN LATIN AMERICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. MARKET RANKING (AS OF 2016)
    • 10.3.1. VENDOR INCLUSION CRITERIA
  • 10.4. COMPETITIVE LEADERSHIP MAPPING (2017)
    • 10.4.1. VISIONARY LEADERS
    • 10.4.2. INNOVATORS
    • 10.4.3. DYNAMIC DIFFERENTIATORS
    • 10.4.4. EMERGING COMPANIES
  • 10.5. COMPETITIVE BENCHMARKING
    • 10.5.1. STRENGTH OF PRODUCT PORTFOLIO
    • 10.5.2. BUSINESS STRATEGY EXCELLENCE

Top 25 companies analyzed for this studies are - Smiths Medical (U.S.), Terumo Medical Corporation (Japan), Becton Dickinson and Company (U.S.), Teleflex Incorporated (U.S.), C.R.Bard, Inc. (U.S.), B Braun Melsungen AG. (Germany), NIPRO Medical Corporation (Japan), Vygon Ltd. (U.K.), Ameco Medical (Egypt), Romson Scientific (India), PRODIMED (France), Edward Lifescience Corporation LLC (U.S.), AngioDynamics (U.S.), Biosensors International Group, Ltd (Singapore), Centurion Medical Products (U.S.), Fresenius Medical Care Asia Pacific Limited (Hong Kong), Access Scientific, LLC (U.S.), 3M. (U.S.), ZOLL Medical Corporation (U.S.), Medtronic Plc (Ireland), Baxter International Inc. (U.S.), Merit Medical System, Inc. (U.S.), Hospira (U.S.), Bionic Medizintechnik GmbH (Germany), Medical Components, Inc. (U.S)

11. COMPANY PROFILES (Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments)*

  • 11.1. BECTON, DICKINSON AND COMPANY
  • 11.2. C.R.BARD, INC.
  • 11.3. TELEFLEX INCORPORATED
  • 11.4. SMITHS MEDICAL, INC.
  • 11.5. B BRAUN MELSUNGEN AG
  • 11.6. ANGIODYNAMICS (NAVILYST MEDICAL, INC)
  • 11.7. TERUMO CORPORATION
  • 11.8. NIPRO MEDICAL CORPORATION
  • 11.9. EDWARDS LIFESCIENCES CORPORATION
  • 11.10. AMECO MEDICAL
  • 11.11. ROMSONS SCIENTIFIC & SURGICAL PVT. LTD.
  • 11.12. PRODIMED

*Details on MarketsandMarkets view, Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, and Recent Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 2: GLOBAL CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 3: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: TUNNELED CATHETERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: NON-TUNNELED CATHETERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: IMPLANTED PORTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: GLOBAL PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 9: PERIPHERAL VASCULAR ACCESS DEVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: PERIPHERAL SHORT DEVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: PERIPHERAL MIDLINE DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: BUTTERFLY/WINGED STEEL NEEDLES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: VASCULAR ACCESS DEVICES MARKET FOR ACCESSORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 15: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: VASCULAR ACCESS DEVICES MARKET FOR FLUID AND NUTRITION ADMINISTRATION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS AND TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 20: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: VASCULAR ACCESS DEVICES MARKET SIZE FOR CLINICS AND AMBULATORY CARE CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 28: NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 30: INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED
  • TABLE 31: INDICATIVE LIST OF RECENT EVENTS IN THE U.S.
  • TABLE 32: U.S.: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 33: U.S.: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 34: U.S.: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 35: U.S.: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 36: U.S.: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 37: CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 38: CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 39: CANADA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 40: CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 41: CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 42: GERIATRIC POPULATION IN EUROPEAN COUNTRIES (AS A PERCENTAGE OF THE TOTAL)
  • TABLE 43: EUROPE: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 44: EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: E-3: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: E-3: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: E-3: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: E-3: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 53: E-3: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 54: ROE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: ROE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: ROE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 57: ROE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 58: ROE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA -PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 62: ASIA-PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 63: ASIA-PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 64: PERCENTAGE OF OBESE POPULATION IN LATIN AMERICAN COUNTRIES
  • TABLE 65: ROW: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 66: ROW: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: ROW: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: ROW: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 69: ROW: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH METHODOLOGY: GLOBAL VASCULAR ACCESS DEVICES
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 4: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: RESEARCH DESIGN: GLOBAL VASCULAR ACCESS DEVICES
  • FIGURE 8: DATA TRIANGULATION METHODOLOGY
  • FIGURE 9: GLOBAL VASCULAR ACCESS DEVICES MARKET, BY TYPE (2017)
  • FIGURE 10: GLOBAL VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 11: GLOBAL VASCULAR ACCESS DEVICES MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 12: GEOGRAPHICAL SNAPSHOT OF THE VASCULAR ACCESS DEVICES MARKET
  • FIGURE 13: RISING PREVALENCE OF LIFESTYLE DISEASES IS THE MAJOR FACTOR DRIVING THE GROWTH OF THE VASCULAR ACCESS DEVICES MARKET
  • FIGURE 14: CENTRAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 15: DRUG ADMINISTRATION SEGMENT WILL CONTINUE TO DOMINATE THE VASCULAR ACCESS DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: HOSPITALS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 17: APAC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 18: GLOBAL VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: CENTRAL VASCULAR ACCESS DEVICES TO COMMAND THE LARGEST SHARE OF THE GLOBAL VASCULAR ACCESS DEVICES MARKET IN 2017
  • FIGURE 20: PERIPHERALLY INSERTED CENTRAL CATHETERS TO COMMAND THE LARGEST SHARE OF THE GLOBAL CENTRAL VASCULAR ACCESS DEVICES MARKET IN 2017
  • FIGURE 21: PERIPHERAL SHORT DEVICES TO COMMAND THE LARGEST SHARE OF THE GLOBAL PERIPHERAL VASCULAR ACCESS DEVICES MARKET IN 2017
  • FIGURE 22: DRUG ADMINISTRATION TO FORM THE LARGEST END-USER SEGMENT IN THE VASCULAR ACCESS DEVICES MARKET IN 2017
  • FIGURE 23: HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN THE VASCULAR ACCESS DEVICES MARKET IN 2017
  • FIGURE 24: NORTH AMERICA TO DOMINATE THE VASCULAR ACCESS DEVICES MARKET IN 2017
  • FIGURE 25: NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
  • FIGURE 26: EUROPE: VASCULAR ACCESS DEVICES SNAPSHOT
  • FIGURE 27: CANCER INCIDENCE IN EU-3
  • FIGURE 28: ASIA-PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
  • FIGURE 29: ROW: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
  • FIGURE 30: GLOBAL VASCULAR ACCESS DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2016)
  • FIGURE 31: COMPETITIVE LEADERSHIP MAPPING: VASCULAR ACCESS DEVICE MARKET
  • FIGURE 32: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 33: C.R.BARD INC. COMPANY SNAPSHOT (2016)
  • FIGURE 34: TELEFLEX INCORPORATED. COMPANY SNAPSHOT (2016)
  • FIGURE 35: SMITHS MEDICAL INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 36: B BRAUN MELSUNGEN AG COMPANY SNAPSHOT (2016)
  • FIGURE 37: ANGIODYNAMICS COMPANY SNAPSHOT (2016)
  • FIGURE 38: TERUMO CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 39: NIPRO MEDICAL CORPORATION COMPANY SNAPSHOT (2016)
  • FIGURE 40: EDWARDS LIFESCIENCES CORPORATION COMPANY SNAPSHOT (2016)
Back to Top